HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A mycolic acid-specific CD1-restricted T cell population contributes to acute and memory immune responses in human tuberculosis infection.

Abstract
Current tuberculosis (TB) vaccine strategies are largely aimed at activating conventional T cell responses to mycobacterial protein antigens. However, the lipid-rich cell wall of Mycobacterium tuberculosis (M. tuberculosis) is essential for pathogenicity and provides targets for unconventional T cell recognition. Group 1 CD1-restricted T cells recognize mycobacterial lipids, but their function in human TB is unclear and their ability to establish memory is unknown. Here, we characterized T cells specific for mycolic acid (MA), the predominant mycobacterial cell wall lipid and key virulence factor, in patients with active TB infection. MA-specific T cells were predominant in TB patients at diagnosis, but were absent in uninfected bacillus Calmette-Guérin-vaccinated (BCG-vaccinated) controls. These T cells were CD1b restricted, detectable in blood and disease sites, produced both IFN-γ and IL-2, and exhibited effector and central memory phenotypes. MA-specific responses contracted markedly with declining pathogen burden and, in patients followed longitudinally, exhibited recall expansion upon antigen reencounter in vitro long after successful treatment, indicative of lipid-specific immunological memory. T cell recognition of MA is therefore a significant component of the acute adaptive and memory immune response in TB, suggesting that mycobacterial lipids may be promising targets for improved TB vaccines.
AuthorsDamien J Montamat-Sicotte, Kerry A Millington, Carrie R Willcox, Suzie Hingley-Wilson, Sarah Hackforth, John Innes, Onn Min Kon, David A Lammas, David E Minnikin, Gurdyal S Besra, Benjamin E Willcox, Ajit Lalvani
JournalThe Journal of clinical investigation (J Clin Invest) Vol. 121 Issue 6 Pg. 2493-503 (Jun 2011) ISSN: 1558-8238 [Electronic] United States
PMID21576820 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Bacterial
  • Antigens, CD1
  • Antitubercular Agents
  • BCG Vaccine
  • Interleukin-2
  • Mycolic Acids
  • Tuberculosis Vaccines
  • Interferon-gamma
Topics
  • Acute Disease
  • Adaptive Immunity
  • Adult
  • Aged
  • Antigens, Bacterial (immunology)
  • Antigens, CD1 (immunology)
  • Antitubercular Agents (therapeutic use)
  • BCG Vaccine (immunology)
  • Cell Wall (immunology)
  • Cells, Cultured (immunology)
  • Female
  • Humans
  • Immunologic Memory (immunology)
  • Interferon-gamma (metabolism)
  • Interleukin-2 (metabolism)
  • Male
  • Middle Aged
  • Mycobacterium tuberculosis (immunology, pathogenicity)
  • Mycolic Acids (immunology)
  • T-Cell Antigen Receptor Specificity
  • T-Lymphocyte Subsets (immunology, metabolism)
  • Tuberculosis (drug therapy, immunology, prevention & control)
  • Tuberculosis Vaccines
  • Virulence
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: